Invesco’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-165,424
| Closed | -$2.43M | – | 3779 |
|
|
2025
Q3 | $2.43M | Buy |
165,424
+13,728
| +9% | +$140K | ﹤0.01% | 2549 |
|
|
2025
Q2 | $1.49M | Buy |
151,696
+35,945
| +31% | +$298K | ﹤0.01% | 2696 |
|
|
2025
Q1 | $842K | Buy |
115,751
+79,515
| +219% | +$695K | ﹤0.01% | 2920 |
|
|
2024
Q4 | $283K | Buy |
36,236
+3,893
| +12% | +$32.1K | ﹤0.01% | 3426 |
|
|
2024
Q3 | $239K | Sell |
32,343
-998
| -3% | -$8.39K | ﹤0.01% | 3478 |
|
|
2024
Q2 | $267K | Sell |
33,341
-1,561
| -4% | -$13.9K | ﹤0.01% | 3540 |
|
|
2024
Q1 | $406K | Sell |
34,902
-66,316
| -66% | -$734K | ﹤0.01% | 3421 |
|
|
2023
Q4 | $1.13M | Buy |
101,218
+6,654
| +7% | +$61.2K | ﹤0.01% | 2836 |
|
|
2023
Q3 | $1.46M | Sell |
94,564
-654,653
| -87% | -$11M | ﹤0.01% | 2707 |
|
|
2023
Q2 | $14.2M | Buy |
749,217
+699,301
| +1,401% | +$12.3M | ﹤0.01% | 1560 |
|
|
2023
Q1 | $760K | Sell |
49,916
-6,311
| -11% | -$82.3K | ﹤0.01% | 3040 |
|
|
2022
Q4 | $716K | Sell |
56,227
-54,841
| -49% | -$493K | ﹤0.01% | 3099 |
|
|
2022
Q3 | $643K | Sell |
111,068
-12,288
| -10% | -$54K | ﹤0.01% | 3118 |
|
|
2022
Q2 | $397K | Buy |
+123,356
| New | +$372K | ﹤0.01% | 3441 |
|
|
2021
Q2 | – | Sell |
-33,299
| Closed | -$789K | – | 3982 |
|
|
2021
Q1 | $789K | Buy |
33,299
+2,175
| +7% | +$50.2K | ﹤0.01% | 3144 |
|
|
2020
Q4 | $759K | Buy |
+31,124
| New | +$796K | ﹤0.01% | 3057 |
|
Other funds holding ETNB
Invesco's ETNB Position: Q4 2025 in Review
Invesco sold out of 89bio (ETNB) in Q4 2025, closing a stake of 165,424 shares — an estimated $2.43M sold.
Invesco first reported a position in ETNB in Q4 2020 and held it in 16 quarters. The position peaked at $14.2M in Q2 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- Invesco reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- Invesco sold 165,424 89bio shares in Q4 2025, an estimated $2.43M.
- Invesco first reported a position in 89bio in Q4 2020 and held it in 16 quarters.
- Invesco's 89bio position peaked at $14.2M in Q2 2023.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on Invesco's 13F filing for Q4 2025, filed 19 Feb 2026.